Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (6193)	11/3/1998 8:09:00 AM
From: Henry Niman	Respond to of 9523

Today's WSJ is carrying a review on Enbrel. They aslo mention COX-2 Inhibitors (like MRK's Vioxx and MTC's Celebrex). Details linked to the New Therapeutics table at biocognizance.com

To: Anthony Wong who wrote (6193)	11/3/1998 11:19:00 AM
From: Anthony Wong	Read Replies (3) \| Respond to of 9523

11/03 10:12 Romania approves Viagra for prescription sale BUCHAREST, Nov 3 (Reuters) - The Romanian Health Ministry has approved the anti-impotency drug Viagra for sale on prescription in the country, an official said on Tuesday. "Market studies are still under way so I can't give you a figure on the expected sales," said Gabriel Hanganu, representative in Romania for Pfizer Inc <PFE.N> of the U.S., which manufactures the drug. "Statistics show that around 25 percent of men over 35 in this country have erectile disfunctions, so clearly this is a good market," Hanganu said adding that one pill was expected to cost about 120,000 lei ($12). Romania has a population of 23 million people. Advertisements in several major newspapers in recent months offered both bulk and retail sales of Viagra. moneynet.com@NEWS-P1&Index=0&HeadlineURL=../News/NewsHeadlines.asp&DISABLE_FORM=&NAVSVC=News\Company